# Creative Media & Community Trust Corp: financial statements, quarterly

CMCT · Nasdaq · CIK 908311 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cmct.md) · [Financials](/companies/cmct/financials.md) · [Filings](/companies/cmct/filings.md) · [Insiders](/companies/cmct/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cmct/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7.5](/filings/0000908311-24-000063.md) | [9.5 d](/filings/0000908311-25-000017.md) | [11.3](/filings/0000908311-25-000038.md) | [11.7](/filings/0000908311-25-000067.md) | [6.8](/filings/0000908311-25-000096.md) | [7.9 d](/filings/0000908311-26-000018.md) | [12.1](/filings/0000908311-26-000054.md) | [11.2](/filings/0000908311-26-000098.md) | [7.2](/filings/0000908311-25-000096.md) | [9.1 d](/filings/0000908311-26-000018.md) | [11.9](/filings/0000908311-26-000054.md) | [12.2](/filings/0000908311-26-000098.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [9.7](/filings/0000908311-24-000063.md) | [10.4 d](/filings/0000908311-25-000017.md) | [9.0](/filings/0000908311-25-000038.md) | [9.2](/filings/0000908311-25-000067.md) | [9.6](/filings/0000908311-25-000096.md) | [9.1 d](/filings/0000908311-26-000018.md) | [9.8](/filings/0000908311-26-000054.md) | [10.2](/filings/0000908311-26-000098.md) | [10.3](/filings/0000908311-25-000096.md) | [9.9 d](/filings/0000908311-26-000018.md) | [9.1](/filings/0000908311-26-000054.md) | [9.0](/filings/0000908311-26-000098.md) |
| Income tax | $m | [0.6](/filings/0000908311-24-000063.md) | [0.3 d](/filings/0000908311-25-000017.md) | [0.3](/filings/0000908311-25-000038.md) | [0.3](/filings/0000908311-25-000067.md) | [0.0](/filings/0000908311-25-000096.md) | [0.2 d](/filings/0000908311-26-000018.md) | [0.1](/filings/0000908311-26-000054.md) | [0.2](/filings/0000908311-26-000098.md) | [0.1](/filings/0000908311-25-000096.md) | [0.1 d](/filings/0000908311-26-000018.md) | [0.0](/filings/0000908311-26-000054.md) | [0.0](/filings/0000908311-26-000098.md) |
| Net income | $m | [(15.8)](/filings/0000908311-24-000063.md) | [(8.4) d](/filings/0000908311-25-000017.md) | [(3.7)](/filings/0000908311-25-000038.md) | [(0.8)](/filings/0000908311-25-000067.md) | [(10.4)](/filings/0000908311-25-000096.md) | [(10.3) d](/filings/0000908311-26-000018.md) | [(6.1)](/filings/0000908311-26-000054.md) | [(9.0)](/filings/0000908311-26-000098.md) | [(12.5)](/filings/0000908311-25-000096.md) | [(11.4) d](/filings/0000908311-26-000018.md) | [(8.3)](/filings/0000908311-26-000054.md) | [(9.9)](/filings/0000908311-26-000098.md) |
| Diluted EPS | $ per share | [(0.94)](/filings/0000908311-24-000063.md) | not reported | [(125.46)](/filings/0000908311-25-000038.md) | [(98.64)](/filings/0000908311-25-000067.md) | [(305.04)](/filings/0000908311-25-000096.md) | not reported | [(1983.00)](/filings/0000908311-26-000054.md) | [(1784.88)](/filings/0000908311-26-000098.md) | [(23.52)](/filings/0000908311-25-000096.md) | not reported | [(70.52)](/filings/0000908311-26-000054.md) | [(4.03)](/filings/0000908311-26-000098.md) |
| Basic EPS | $ per share | [(0.94)](/filings/0000908311-24-000063.md) | not reported | [(125.46)](/filings/0000908311-25-000038.md) | [(98.64)](/filings/0000908311-25-000067.md) | [(305.04)](/filings/0000908311-25-000096.md) | not reported | [(1983.00)](/filings/0000908311-26-000054.md) | [(1784.88)](/filings/0000908311-26-000098.md) | [(23.52)](/filings/0000908311-25-000096.md) | not reported | [(70.52)](/filings/0000908311-26-000054.md) | [(4.03)](/filings/0000908311-26-000098.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [19.3](/filings/0000908311-24-000063.md) | [19.3](/filings/0000908311-25-000017.md) | [21.3](/filings/0000908311-25-000038.md) | [29.3](/filings/0000908311-25-000067.md) | [18.5](/filings/0000908311-25-000096.md) | [20.3](/filings/0000908311-26-000018.md) | [19.8](/filings/0000908311-26-000054.md) | [27.8](/filings/0000908311-26-000098.md) | [17.3](/filings/0000908311-25-000096.md) | [15.4](/filings/0000908311-26-000098.md) | [15.8](/filings/0000908311-26-000054.md) | [12.8](/filings/0000908311-26-000098.md) |
| Total assets | $m | [898](/filings/0000908311-23-000076.md) | [891](/filings/0000908311-25-000017.md) | [888](/filings/0000908311-24-000019.md) | [891](/filings/0000908311-24-000043.md) | [868](/filings/0000908311-24-000063.md) | [890](/filings/0000908311-26-000018.md) | [882](/filings/0000908311-25-000038.md) | [885](/filings/0000908311-25-000067.md) | [872](/filings/0000908311-25-000096.md) | [859](/filings/0000908311-26-000098.md) | [792](/filings/0000908311-26-000054.md) | [783](/filings/0000908311-26-000098.md) |
| Total liabilities | $m | [523](/filings/0000908311-23-000076.md) | [514](/filings/0000908311-25-000017.md) | [515](/filings/0000908311-24-000019.md) | [530](/filings/0000908311-24-000043.md) | [524](/filings/0000908311-24-000063.md) | [562](/filings/0000908311-26-000018.md) | [567](/filings/0000908311-25-000038.md) | [584](/filings/0000908311-25-000067.md) | [589](/filings/0000908311-25-000096.md) | [593](/filings/0000908311-26-000098.md) | [535](/filings/0000908311-26-000054.md) | [537](/filings/0000908311-26-000098.md) |
| Long-term debt | $m | [470](/filings/0000908311-23-000076.md) | [472](/filings/0000908311-25-000017.md) | [473](/filings/0000908311-24-000019.md) | [485](/filings/0000908311-24-000043.md) | [478](/filings/0000908311-24-000063.md) | [506](/filings/0000908311-26-000018.md) | [513](/filings/0000908311-25-000038.md) | [536](/filings/0000908311-25-000067.md) | [528](/filings/0000908311-25-000096.md) | [510](/filings/0000908311-26-000098.md) | [500](/filings/0000908311-26-000054.md) | [499](/filings/0000908311-26-000098.md) |
| Shareholders' equity | $m | [372](/filings/0000908311-23-000076.md) | [374](/filings/0000908311-25-000017.md) | [370](/filings/0000908311-24-000019.md) | [351](/filings/0000908311-24-000043.md) | [321](/filings/0000908311-24-000063.md) | [305](/filings/0000908311-26-000018.md) | [293](/filings/0000908311-25-000038.md) | [287](/filings/0000908311-25-000067.md) | [282](/filings/0000908311-25-000096.md) | [265](/filings/0000908311-26-000098.md) | [256](/filings/0000908311-26-000054.md) | [245](/filings/0000908311-26-000098.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.3 d](/filings/0000908311-24-000063.md) | [(4.8) d](/filings/0000908311-25-000017.md) | [1.6](/filings/0000908311-25-000038.md) | [3.9 d](/filings/0000908311-25-000067.md) | [10.3 d](/filings/0000908311-25-000096.md) | [1.1 d](/filings/0000908311-26-000018.md) | [1.2](/filings/0000908311-26-000054.md) | [(2.5) d](/filings/0000908311-26-000098.md) | [3.7 d](/filings/0000908311-25-000096.md) | [3.3 d](/filings/0000908311-26-000018.md) | [(26.0)](/filings/0000908311-26-000054.md) | [3.4 d](/filings/0000908311-26-000098.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [1.9 d](/filings/0000908311-24-000063.md) | [1.9 d](/filings/0000908311-25-000017.md) | [1.9](/filings/0000908311-25-000038.md) | [1.9 d](/filings/0000908311-25-000067.md) | [1.9 d](/filings/0000908311-25-000096.md) | [0.0 d](/filings/0000908311-26-000018.md) | [0.0](/filings/0000908311-25-000038.md) | [0.0 d](/filings/0000908311-25-000067.md) | [0.0 d](/filings/0000908311-25-000096.md) | [0.0 d](/filings/0000908311-26-000018.md) | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000908311-23-000076.md) | [0.0 d](/filings/0000908311-24-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.2](/filings/0000908311-23-000076.md) | [22.7](/filings/0000908311-24-000019.md) | [22.7](/filings/0000908311-24-000043.md) | [24.4](/filings/0000908311-24-000063.md) | [0.1](/filings/0000908311-25-000038.md) | [0.1](/filings/0000908311-25-000067.md) | [0.1](/filings/0000908311-25-000096.md) | [0.0](/filings/0000908311-26-000054.md) | [0.0](/filings/0000908311-26-000098.md) | [0.8](/filings/0000908311-25-000096.md) | [0.5](/filings/0000908311-26-000054.md) | [2.7](/filings/0000908311-26-000098.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,947,493 at 2026-08-06, from the cover of the [10-Q filed 2026-08-14](/filings/0000908311-26-000098.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.